Flow cytometry: A flexible tool for biomarker research

Bioanalysis

Volumn 4, Issue 20, 2012, Pages 2471-2483

  Barnard, Ruth M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR2 ANTAGONIST; RITUXIMAB; TGN 1412;

ACOUSTIC FOCUSING CYTOMETER; ANALYTICAL EQUIPMENT; APOPTOSIS; AUTOFLUORESCENCE; CELIAC DISEASE; CELL CYCLE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER PROGRAM; CYTOMETRY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRODYNAMICS; IMAGING FLOW CYTOMETER; IMMUNOASSAY; IMMUNOPHENOTYPING; INTERNALIZATION; MEDICAL RESEARCH; MONITORING; NONHUMAN; PATHOGENESIS; PHOSPHOFLOW; RECEPTOR OCCUPANCY; REVIEW; RHEUMATOID ARTHRITIS; SEPARATION TECHNIQUE; STAINING; UPREGULATION;

BIOLOGICAL MARKERS; CELL CYCLE; CLUSTER ANALYSIS; CYTOKINES; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; T-LYMPHOCYTES;

EID: 84869462875     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.225     Document Type: Review

References (61)

1. Jaye DL, Bray RA, Gebel HM, Harris WA, Waller EK. Translational applications of flow cytometry in clinical practice. J. Immunol. 188(10), 4715-4719 (2012).
2. Curtis MG, Walker B, Denny TN. Flow cytometric methods for prenatal and neonatal diagnosis. J. Immunol. Methods 363(2), 198-209 (2011).
3. Hristozova T, Konschak R, Budach V, Tinhofer I. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers. Cytometry A 81(6), 489-495 (2012).
4. Chattopadhyay PK, Hogerkorp CM, Roederer M. A chromatic explosion: the development and future of multiparameter flow cytometry. Immunology 125(4), 441-449 (2008)
5. Frangogiannis NG. Biomarkers: hopes and challenges in the path from discovery to clinical practice. Transl. Res. 159(4), 197-204 (2012).
6. Biomarkers Definitions Working Group. Biomarkers and surrogate end points: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69(3), 89-95 (2001).
7. Litwin V, O'Gorman MR. Flow cytometry-based biomarkers in translational medicine and drug development. J. Immunol. Methods 363(2), 101-102 (2011).
8. van Gool AJ, Henry B, Sprengers ED. From biomarker strategies to biomarker activities and back. Drug Discov. Today 15(3-4), 121-126 (2010).
9. O'Hara DM, Xu Y, Liang Z, Reddy MP, Wu DY, Litwin V. Recommendations for the validation of flow cytometric testing during drug development: II assays. J. Immunol. Methods 363(2), 120-134 (2011).
10. Houghton R, Chamberlain J. Analytical challenges in the qualification and validation of pharmacodynamic biomarkers. Bioanalysis 3(9), 945-948 (2011).
11. Wyant T, Lackey A, Green M. Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist. J. Transl. Med. 6(76) 1-12 (2008).
12. Sewell WA , Smith SA. Polychromatic flow cytometry in the clinical laboratory. Pathology 43(6), 580-591 (2011).
13. Marsee DK, Li B, Dorfman DM. Single tube, six-color flow cytometric analysis is a sensitive and cost-effective technique for assaying clonal plasma cells. Am. J. Clin. Pathol. 133(5), 694-699 (2010).
14. Rawstron AC, Orfao A, Beksac M et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica 93(3), 431-438 (2008). (Pubitemid 351398645)
15. Yuan CM, Stetler-Stevenson M. Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma. Semin. Hematol. 48(1), 32-38 (2011).
16. Paiva B, Vidriales MB, Cervero J et al. Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation. Blood 112(10), 4017-4023 (2008).
17. Gupta R, Bhaskar A, Kumar L, Sharma A, Jain P. Flow cytometric immunophenotyping and minimal residual disease analysis in multiple myeloma. Am. J. Clin. Pathol. 132(5), 728-732 (2009).
18. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 111(8), 3941-3967 (2008).
19. Suchard MS, Mayne E, Green VA et al. FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity. PLoS ONE 5(7), e11762 (2010).
20. Tuaillon E, Al TY, Baillat V et al. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count. Cytometry B Clin. Cytom. 76(4), 249-260 (2009).
21. Glencross DK, Janossy G, Coetzee LM et al. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort. Cytometry B Clin. Cytom. 74(Suppl. 1), S131-S140 (2008). (Pubitemid 351569281)
22. Coetzee LM, Tay SS, Lawrie D, Janossy G, Glencross DK. From research tool to routine test: CD38 monitoring in HIV patients. Cytometry B Clin. Cytom. 76(6), 375-384 (2009).
23. Leon F. Flow cytometry of intestinal intraepithelial lymphocytes in celiac disease. J. Immunol. Methods 363(2), 177-186 (2011).
24. Sellam J, Rouanet S, Hendel-Chavez H et al. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. Arthritis Rheum. 63(12), 3692-3701 (2011).
25. Lazaar AL, Sweeney LE, MacDonald AJ, Alexis NE, Chen C, Tal-Singer R. SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. Br. J. Clin. Pharmacol. 72(2), 282-293 (2011).
26. Wolanczyk-Medrala A, Gogolewski G, Liebhart J et al. A new variant of the basophil activation test for allergen-induced basophil CD63 upregulation. The effect of cetirizine. J. Investig. Allergol. Clin. Immunol. 19(6), 465-473 (2009).
27. Krutzik PO, Nolan GP. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat. Methods 3(5), 361-368 (2006).
28. Levis M. Phospho-specific flow: fixating on the target. Clin. Cancer Res. 18(6), 1493-1495 (2012).
29. Comin-Anduix B, Sazegar H, Chodon T et al. Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma. PLoS ONE 5(9), e12711 (2010).
30. Dieterlen MT, Eberhardt K, Tarnok A, Bittner HB, Barten MJ. Flow cytometry-based pharmacodynamic monitoring after organ transplantation. Methods Cell Biol. 103, 267-284 (2011).
31. Millan O, Benitez C, Guillen D et al. Biomarkers of immunoregulatory status in stable liver transplant recipients undergoing weaning of immunosuppressive therapy. Clin. Immunol. 137(3), 337-346 (2010).
32. Vafadari R, Weimar W, Baan CC. Phosphospecific flow cytometry for pharmacodynamic drug monitoring: analysis of the JAK-STAT signaling pathway. Clin. Chim. Acta 413(17-18), 1398-1405 (2012).
33. Dieterlen MT, Bittner HB, Klein S et al. Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood. Cytometry B Clin. Cytom. 82(3), 151-157 (2012).
34. Lepin EJ, Zhang Q, Zhang X et al. Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts. Am. J. Transplant. 6(7), 1560-1571 (2006). (Pubitemid 43948221)
35. McKinnon LR, Nyanga B, Chege D et al. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J. Immunol. 187(11), 6032-6042 (2011).
36. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464(7286), 217-223 (2010).
37. Akoglu B, Kriener S, Martens S et al. Interleukin-2 in CD8+ T cells correlates with Banff score during organ rejection in liver transplant recipients. Clin. Exp. Med. 9(4), 259-262 (2009).
38. Mirabet S, Gelpi C, Roldan C et al. Assessment of immunological markers as mediators of graft vasculopathy development in heart transplantation. Transplant. Proc. 43(6), 2253-2256 (2011).
39. Bergeron M, Ding T, Elharti E et al. Evaluation of a dry format reagent alternative for CD4 T-cell enumeration for the FACSCount system: a report on a Moroccan-Canadian study. Cytometry B Clin. Cytom. 78(3), 188-193 (2010).
40. Dieye TN, Diaw PA, Daneau G et al. Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thermoresistant reagents. J. Immunol. Methods 372(1-2), 7-13 (2011).
41. Mowbray CE, Bell AS, Clarke NP et al. Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist. Bioorg. Med. Chem. Lett. 21(21), 6596-6602 (2011).
42. Zarbock A, Ley K. Neutrophil adhesion and activation under flow. Microcirculation 16(1), 31-42 (2009).
43. Estevam J, Danaee H, Liu R, Ecsedy J, Trepicchio WL, Wyant T. Validation of a flow cytometry based G2M delay cell cycle assay for use in evaluating the pharmacodynamic response to Aurora A inhibition. J. Immunol. Methods 363(2), 135-142 (2011).
44. Feuerstein GZ, Chavez J. Translational medicine for stroke drug discovery: the pharmaceutical industry perspective. Stroke 40(Suppl. 3), S121-S125 (2009).
45. Eastwood D, Findlay L, Poole S et al. Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br. J. Pharmacol. 161(3), 512-526 (2010).
46. Clark SM, Narayanan PK, Fort MM. Determination of absolute counts of circulating regulatory T cells in cynomolgus macaques using an optimized flow cytometric method. Toxicol. Pathol. 40(1), 107-112 (2012).
47. Inngjerdingen M, Kveberg L, Naper C, Vaage JT. Natural killer cell subsets in man and rodents. Tissue Antigens 78(2), 81-88 (2011).
48. Barnard RM, Hincks JS. Eosinophil shape change across the species - using a CB2 agonist as a case study. Presented at: 2nd Flow Cytometry UK Conference. Oxford, UK, 15-17 July 2012.
49. Autissier P, Soulas C, Burdo TH, Williams KC. Immunophenotyping of lymphocyte, monocyte and dendritic cell subsets in normal rhesus macaques by 12-color flow cytometry: clarification on DC heterogeneity. J. Immunol. Methods 360(1-2), 119-128 (2010).
50. Kuhrt D, Faith S, Hattemer A et al. Naive and memory B cells in the rhesus macaque can bedifferentiated by surface expression of CD27 and have differential responses to CD40 ligation. J. Immunol. Methods 363(2), 166-176 (2011).
51. Vugmeyster Y, Howell K, Bakshi A, Flores C, Hwang O, McKeever K. B-cell subsets in blood and lymphoid organs in Macaca fascicularis. Cytometry A 61(1), 69-75 (2004). (Pubitemid 39166597)
52. Wu DY, Patti-Diaz L, Hill CG. Development and validation of flow cytometry methods for pharmacodynamic clinical biomarkers. Bioanalysis 2(9), 1617-1626 (2010).
53. Nolan GP. Flow cytometry in the post fluorescence era. Best Pract. Res. Clin. Haematol. 24(4), 505-508 (2011).
54. Bendall SC, Nolan GP, Roederer M, Chattopadhyay PK. A deep profiler's guide to cytometry. Trends Immunol. 33(7), 323-332 (2012).
55. Bendall SC, Simonds EF, Qiu P et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332(6030), 687-696 (2011).
56. Newell EW, Sigal N, Bendall SC, Nolan GP, Davis MM. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36(1), 142-152 (2012).
57. Covey TM, Cesano A, Parkinson DR. Single-cell network profiling (SCNP) by flow cytometry in autoimmune disease. Autoimmunity 43(7), 550-559 (2010).
58. Aghaeepour N, Chattopadhyay PK, Ganesan A et al. Early immunologic correlates of HIV protection can be identified from computational analysis of complex multivariate T-cell flow cytometry assays. Bioinformatics 28(7), 1009-1016 (2012).
59. van Dongen JJ, Lhermitte L, Bottcher S et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 26(9), 1908-1975 (2012).
60. Sekiguchi DR, Sutter JA, Rickels MR et al. Analysis of B cell subsets following pancreatic islet cell transplantation in a patient with type 1 diabetes by cytometric fingerprinting. J. Immunol. Methods 363(2), 233-244 (2011).
61. Buckman C, George TC, Friend S et al. High throughput, parallel imaging and biomarker quantification of human spermatozoa by ImageStream flow cytometry. Syst. Biol. Reprod. Med. 55(5-6), 244-251 (2009).